These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25196848)

  • 1. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
    Campillo-Artero C
    Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
    Scott B
    Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient groups accuse European parliament of putting economic interests ahead of safety on medical devices.
    Cohen D
    BMJ; 2013 Oct; 347():f6446. PubMed ID: 24157501
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation and Device Development: Tips for Optimizing Your Experience With the Food and Drug Administration.
    Brooks SS
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):109-115. PubMed ID: 28673647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What type of clinical evidence is needed to assess medical devices?
    Tarricone R; Boscolo PR; Armeni P
    Eur Respir Rev; 2016 Sep; 25(141):259-65. PubMed ID: 27581825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and safe adoption of new medical devices and procedures.
    Campbell B
    Br Med Bull; 2013; 107():5-18. PubMed ID: 23896485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neither protective nor harmonized: the crossborder regulation of medical devices in the EU.
    Jarman H; Rozenblum S; Huang TJ
    Health Econ Policy Law; 2021 Jan; 16(1):51-63. PubMed ID: 32631465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of alternative medical device approval processes on costs and health.
    George BP; Venkataraman V; Dorsey ER; Johnston SC
    Clin Transl Sci; 2014 Oct; 7(5):368-75. PubMed ID: 25185975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Commission's proposals for a new regulation to govern medical devices.
    Tofield A
    Eur Heart J; 2013 May; 34(19):1385-6. PubMed ID: 23674653
    [No Abstract]   [Full Text] [Related]  

  • 15. [Benefit assessments for medical technology devices: Strategic challenges for clinical research].
    Schönermark MP
    HNO; 2015 Aug; 63(8):586-8. PubMed ID: 26204843
    [No Abstract]   [Full Text] [Related]  

  • 16. Cannabis: high time for evidence-based policies.
    The Lancet Oncology
    Lancet Oncol; 2017 Jan; 18(1):1. PubMed ID: 28049567
    [No Abstract]   [Full Text] [Related]  

  • 17. Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.
    Kramer DB; Tan YT; Sato C; Kesselheim AS
    Food Drug Law J; 2014; 69(1):1-23, i. PubMed ID: 24772683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EU and member state medical devices regulation.
    Altenstetter C
    Int J Technol Assess Health Care; 2003; 19(1):228-48. PubMed ID: 12701954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.